Niron Magnetics Opens the World’s First Manufacturing Facility for Powerful Rare-Earth-Free Permanent Magnets
Next-generation technology will help engineering students acquire hands-on skills to succeed in the modern workforce
VTU Transforms Engineering Education in Karnataka with Reconfigurable Instrumentation from Liquid Instruments
Next-generation technology will help engineering students acquire hands-on skills to succeed in the modern workforce
AM Batteries Ships First Rolls of Electrodes to Make EVs More Affordable
Leading US battery equipment manufacturer hits major milestone in scaling dry battery electrode technology for commercialization; works with major battery cell supplier for validation
BioSkryb Genomics Partners with the Human Cell Atlas to Advance Access to the Next Generation of Single-Cell Technology
New partnership will increase access to BioSkryb’s industry-leading single-cell multiomics technology
GelSight Appoints Aerospace Industry Expert Troy Lambeth to Board of Directors
Troy brings over 30 years of leadership experience and aviation expertise to GelSight’s board
Opscura Appoints Industry Veteran as Chief Revenue Officer to Lead Market Expansion
New appointment supports OT Security company with rapid growth strategy
Adaptive Surface Technologies Releases New 53-Month Performance Data for Non-Toxic Marine Anti-Fouling Product
AST’s SLIPS™ Dolphin II and N4 have been subjected to 53 months of exposure testing, led by an international third-party
Xendee and UIUC Deliver Phased Approach to Power Data Centers with Renewables and Advanced Nuclear
Xendee and the University of Illinois Urbana-Champaign partner to develop and provide groundbreaking low-carbon solutions for powering data centers
NTx Services Launches to Supercharge Next Generation mRNA Research
NTx’s new services offering provides faster and more affordable high-integrity, complex mRNA production powered by NTxscribe®
Presentation at the 2024 International HBV Meeting Highlights Antiviral Activity of EBT-107 as a Potential Anti-HBV Therapy
Excision BioTherapeutics today announced that it presented data from its program for Hepatitis B virus, EBT-107, at the 2024 International HBV Meeting